China
Coronavirus & leverage: Room to maneuver?
Economic disruption caused by the coronavirus outbreak is likely to leave many private equity portfolio companies in breach of their leverage covenants. Borrowers and lenders are looking for a fix
Chinese cultural education business secures $21m Series B
Qinhan Hutong, a Chinese education provider that offers an art and culture curriculum, has raised RMB150 million ($21 million) in Series B funding from Mingde Chuancheng, a Shanghai-based education and consulting company.
GLP backs $1.37b take-private of Hong Kong's Li & Fung
The founders of Hong Kong-listed Li & Fung have teamed up with PE-owned warehouse operator GLP on a take-private offer that values their company at HK$10.7 billion ($1.37 billion).
Sequoia invests $171m in Chinese dairy products manufacturer
Sequoia Capital China has invested of RMB1.2 billion ($171 million) in Chinese dairy products manufacturer Junlebao, becoming the largest institutional investor with a 15.26% stake.
Deal focus: Neolix finds its self-driving niche
Unable to achieve the cost-effectiveness of America's driverless grocery delivery services in China, Neolix refocused on transporting meals. Investor Yunqi Partners believes simple solutions mean quicker commercialization
Vision Plus hits $400m first close on third China fund
Vision Plus Capital has completed the first closing on its third US dollar-denominated fund with $400 million in commitments. The vehicle comprises separate venture and growth equity capital pools.
Deal focus: 51CTO's prescient training pivot
Chinese IT platform 51CTO switched from online media to online training five years ago and hasn't looked back. With $20 million in Series C funding, the company wants to sustain its rise
PE-backed InnoCare raises $288m in Hong Kong IPO
InnoCare Pharma, a private equity-backed Chinese drug developer focused on treatments for cancer and autoimmune diseases, has raised HK$2.24 billion ($288 million) through a Hong Kong IPO.
Chinese drug developer RemeGen raises $100m
RemeGen, a Chinese drug developer, has raised a $100 million round led by Lilly Asia Ventures and Lake Bleu Capital.
Chinese insurtech player Insgeek gets $25m Series C
SIG and China Renaissance New Economy Fund have co-led a $25 million Series C round for Insgeek, a Chinese insurance technology specialist.
Everest leads $24m round for China's Cloudwise
Chinese enterprise digital solutions provider Cloudwise has raised $24 million in an extended Series D round led by Everest Venture Capital. Sequoia Capital China, WestSummit Capital, ASG and Koala Fund also participated.
China's Harbour BioMed gets $75m Series B extension
China-based biotech developer Harbour BioMed has closed an extended Series B round with a fresh $75 million commitment from a group of VCs. It initially raised $85 million in 2018.
Europe's Eurazeo promotes Asian agenda
Eurazeo’s Europe-China fund – a joint effort with China Investment Corporation (CIC) and BNP Paribas – will come online at the end of this month with an initial EUR400 million ($445 million) in dry powder. It is the France-based GP’s latest milestone...
ByteDance invests $26m in Chinese talent manager
Chinese celebrity management agency Mountain Top has closed a RMB180 million ($26 million) Serie B funding round provided by ByteDance Technology, operator of the Toutiao news aggregation and TikTok short video platforms.
UK strategic acquires China's VC-backed Yimian Data
UK-based enterprise IT services provider Ascential has acquired Yimian Data, a Chinese e-commerce analytics business backed by local VC firms ZhenFund and Legend Star.
CDH closes sixth China PE fund at $1.5b
CDH Investments has closed its sixth flagship US dollar-denominated fund with $1.5 billion in commitments. The initial target was $2.5 billion.
Meituan-Dianping invests $87m in China food supply chain player
Shenzhen-based agricultural products distributor Wangjiahuan has raised RMB600 million ($87 million) in Series B funding led by Meituan-Dianping. Existing backer Hidden Hill Capital - a PE firm established by warehouse operator GLP - also took part.
US GP Jaguar acquires China logistics player
US private equity investor Jaguar Growth Partners has launched its first Asia fund with the acquisition of Chinese logistics operator Brilliant.
Coronavirus in China: Back from the brink
China GPs are trying to navigate the coronavirus uncertainty and help portfolio companies pick up the pieces, whether that means cutting costs or realizing new revenue streams
Deal focus: Linctex makes SaaS pay in China
Vision Plus Capital identified Linctex after conducting a deep dive into China's textile industry supply chain. It believes the company has the right model - and is in the right industry - to make software-as-a-service work
Fund focus: CMC widens its sweet spot
Having grown its assets under management to $2.5 billion following the close of Fund III, China's CMC Captial Group wants to be seen as more than just a media sector specialist
China facilitates faster public market exits for PE and VC investors
China's securities regulator has revised rules on public market sell-downs, making it easier for PE and VC investors to exit their positions in portfolio companies post-IPO.
China's GenFleet Therapeutics raises $50m Series B
CDH Investments and Shenzhen Capital Group have co-led a $50 million Series B round for GenFleet Therapeutics, a Chinese drug developer.
China's Billionhome leads $14m round for space tech player
Chinese private equity firm Billionhome Capital has led a RMB100 million ($14.4 million) investment in local satellite technology supplier Mino Space.